Systemic Bacillus-Calmette Guerin Infection after Transurethral Administration for Superficial Bladder Carcinoma
- 1 October 1989
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 142 (4) , 1073-1074
- https://doi.org/10.1016/s0022-5347(17)38994-2
Abstract
It is well known that intravesical bacillus Calmette-Guerin therapy is a safe and effective treatment for superficial bladder carcinoma with few serious complications. However, we report a case of pneumonitis, hepatitis, azotemia, fever and pancytopenia in a patient after transurethral administration of bacillus Calmette-Guerin. Even though severe systemic complications are rare, patients who have high fevers of signs of other systemic manifestations require documentation of the extent of the infection. Also, we address the use of prophylactic antituberculous drugs, not only to prevent these symptoms but also to raise the questions of diminishing the immunological effect of the treatment.Keywords
This publication has 7 references indexed in Scilit:
- Granulomatous Hepatitis Following Intravesical Bacillus Calmette-guerin Therapy for Bladder CarcinomaJournal of Urology, 1987
- Complications of Bacillus Calmette-Guerin Immunotherapy in 1,278 Patients with Bladder CancerJournal of Urology, 1986
- SYSTEMIC COMPLICATIONS OF INTRAVESICAL BCG THERAPY FOR BLADDER CANCERThe Lancet, 1985
- Bacillus Calmette-Guerin Immunotherapy for Bladder CancerJournal of Urology, 1985
- The Use of Bacillus Calmette-Guerin in the Therapy of Bladder Carcinoma in SituJournal of Urology, 1985
- Long-Term Results and Complications of Intracavitary Bacillus Calmette-Guerin Therapy for Bladder CancerJournal of Urology, 1984
- A Comparison of Treatment Methods for the Prophylaxis of Recurrent Superficial Bladder TumorsJournal of Urology, 1983